AAAAAA

   
Results: 1-12 |
Results: 12
TOXICITY OF 6-MERCAPTOPURINE AZATHIOPRINE IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE/
Authors: MARION JF
Citation: Jf. Marion, TOXICITY OF 6-MERCAPTOPURINE AZATHIOPRINE IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE/, Inflammatory bowel diseases, 4(2), 1998, pp. 116-117
6-MERCAPTOPURINE (6-MP) - DOES IT INCREASE OR DECREASE THE RISKS OF COLON-CANCER IN CROHNS-DISEASE (CD)
Authors: GOLDSTEIN ES MARION JF WHEELER S PRESENT DH
Citation: Es. Goldstein et al., 6-MERCAPTOPURINE (6-MP) - DOES IT INCREASE OR DECREASE THE RISKS OF COLON-CANCER IN CROHNS-DISEASE (CD), Gastroenterology, 114(4), 1998, pp. 4041-4041
TOXICITIES AND INFECTIONS ASSOCIATED WITH CHRONIC 6-MERCAPTOPURINE (6-MP) USE IN CROHNS-DISEASE (CD) - DO WE NEED TO DISCONTINUE TREATMENT
Authors: GOLDSTEIN ES MARION JF WHEELER S PRESENT DH
Citation: Es. Goldstein et al., TOXICITIES AND INFECTIONS ASSOCIATED WITH CHRONIC 6-MERCAPTOPURINE (6-MP) USE IN CROHNS-DISEASE (CD) - DO WE NEED TO DISCONTINUE TREATMENT, Gastroenterology, 114(4), 1998, pp. 4042-4042
6-MERCAPTOPURINE IS SAFE AND EFFECTIVE FOR PEDIATRIC-PATIENTS WITH IBD
Authors: MARION JF GOLDSTEIN ES PRESENT DH
Citation: Jf. Marion et al., 6-MERCAPTOPURINE IS SAFE AND EFFECTIVE FOR PEDIATRIC-PATIENTS WITH IBD, Gastroenterology, 114(4), 1998, pp. 4226-4226
MEDICAL THERAPY, NOT SURGERY, IS THE APPROPRIATE FIRST LINE TREATMENTFOR CROHNS ENTEROVESICAL FISTULA
Authors: WHEELER SC MARION JF PRESENT DH
Citation: Sc. Wheeler et al., MEDICAL THERAPY, NOT SURGERY, IS THE APPROPRIATE FIRST LINE TREATMENTFOR CROHNS ENTEROVESICAL FISTULA, Gastroenterology, 114(4), 1998, pp. 4555-4555
THE MODERN MEDICAL-MANAGEMENT OF ACUTE, SEVERE ULCERATIVE-COLITIS
Authors: MARION JF PRESENT DH
Citation: Jf. Marion et Dh. Present, THE MODERN MEDICAL-MANAGEMENT OF ACUTE, SEVERE ULCERATIVE-COLITIS, European journal of gastroenterology & hepatology, 9(9), 1997, pp. 831-835
THE TREATMENT OF CHOICE FOR PYODERMA-GANGRENOSUM COMPLICATING IBD - INTRAVENOUS CYCLOSPORINE
Authors: FRIEDMAN S MARION JF SCHERL E RUBIN P PRESENT DH
Citation: S. Friedman et al., THE TREATMENT OF CHOICE FOR PYODERMA-GANGRENOSUM COMPLICATING IBD - INTRAVENOUS CYCLOSPORINE, Gastroenterology, 112(4), 1997, pp. 975-975
THE PLACE FOR METHOTREXATE IN THE TREATMENT OF REFRACTORY CROHNS-DISEASE
Authors: MAHADEVAN U MARION JF PRESENT DH
Citation: U. Mahadevan et al., THE PLACE FOR METHOTREXATE IN THE TREATMENT OF REFRACTORY CROHNS-DISEASE, Gastroenterology, 112(4), 1997, pp. 1031-1031
THE APPENDIX AND IBD - APPENDECTOMY DOES NOT PROTECT AGAINST ULCERATIVE-COLITIS
Authors: MARION JF BODIAN CA JANOWITZ HD
Citation: Jf. Marion et al., THE APPENDIX AND IBD - APPENDECTOMY DOES NOT PROTECT AGAINST ULCERATIVE-COLITIS, Inflammatory bowel diseases, 2(3), 1996, pp. 217-221
HOW EFFECTIVE IS CURRENT MEDICAL THERAPY FOR SEVERE ULCERATIVE AND CROHNS COLITIS - AN ANALYTIC REVIEW OF SELECTED TRIALS
Authors: KORNBLUTH A MARION JF SALOMON P JANOWITZ HD
Citation: A. Kornbluth et al., HOW EFFECTIVE IS CURRENT MEDICAL THERAPY FOR SEVERE ULCERATIVE AND CROHNS COLITIS - AN ANALYTIC REVIEW OF SELECTED TRIALS, Journal of clinical gastroenterology, 20(4), 1995, pp. 280-284
APPENDECTOMY, APPENDICITIS, AND INFLAMMATORY BOWEL-DISEASE
Authors: MARION JF BODIAN CA JANOWITZ HD
Citation: Jf. Marion et al., APPENDECTOMY, APPENDICITIS, AND INFLAMMATORY BOWEL-DISEASE, Gastroenterology, 108(4), 1995, pp. 870-870
RARITY OF FISTULAS IN CROHNS-DISEASE OF THE JEJUNUM
Authors: MARION JF LACHMAN P GREENSTEIN AJ SACHAR DB
Citation: Jf. Marion et al., RARITY OF FISTULAS IN CROHNS-DISEASE OF THE JEJUNUM, Gastroenterology, 108(4), 1995, pp. 871-871
Risultati: 1-12 |